Myocardial Injury Following Non-cardiac Surgery
কীওয়ার্ডস
বিমূর্ত
বর্ণনা
Introduction:
It is estimated that > 200 million patients in the world undergo surgery each year of which approximately 10 million would suffer from a myocardial injury in the perioperative period. Mortality is high in this group of patients since it often goes undiagnosed, the patho-physiology of myocardial injury is unclear, non-invasive diagnostic tools are not widely available and treatment is unknown.
Multiple studies have shown that > 10% of patients > 65 years and undergoing non-cardiac surgery have an increase in Troponin T (TnT). In the POISE study including 8331 patients, the authors found that 5.7% of the placebo group suffered from a myocardial injury within the 30-day postoperative period. In the recently published data from the VISION study including > 15,000 patients, the authors demonstrated that patients with peak perioperative TnT values of < 0.01, 0.02, 0.03-0.29 and > 0.30 ng/L had a 30-day mortality of 1%, 4%, 9.3% and 16.9% respectively. Furthermore, an elevated TnT without symptoms or ECG changes are an independent predictor of 30-day mortality. It is possible that some cases of myocardial injury in Non-cardiac surgery (MINS) result from oxygen supply-delivery mismatch due to severe perioperative hypotension, and possibly persistent tachycardia but coronary artery thrombosis cannot be excluded in these patients. It is well known that surgical trauma causes an increase in several pro-inflammatory cytokines which, together with sympathetic over-activity, leads to a hypercoagulable state due to platelet activation, and a predisposition to thrombosis. In one study, it was found that approximately 1/3 of the patients had evidence of intracoronary thrombosis at autopsy.
Myocardial infarction with non-obstructive coronary artery (MINCA) has recently received greater attention in the literature. The underlying patho-physiology responsible for MINCA revealed the presence of a typical myocardial infarct on cardiac magnetic resonance imaging in only 24% of patients, with myocarditis occurring in 33% and no significant abnormality in 26%. A rare cause of MINCA is Takotsubo cardiomyopathy, also called stress cardiomyopathy. Recently, coronary angiography using computerized tomographic angiography (CTA) has added a new dimension to the diagnostic armamentarium available to the clinician. Using advanced imaging techniques and low radiation, it is today possible to determine quite accurately coronary artery anatomy and thereby determine stenotic lesions in the coronary vasculature. Echocardiography can be easily performed by an experienced technician, the images stored digitally and evaluated subsequently by specialists. The availability of continuous perioperative monitoring of several hemodynamic indices as well as regular blood gas analysis, may enable determination of oxygen demand-supply mismatch.
Methods:
This is a case-control study in patients undergoing major, non-cardiac surgery. Permission will be obtained from the Ethics committee prior to patient recruitment and Good Clinical Practice guidelines will be followed in all patients. Verbal and written informed consent will be obtained from all patients willing to participate in the study. The study will be registered in an international database before start of patient recruitment. Patients would be assessed for inclusion in the preoperative anaesthetic clinic and a detailed preoperative history taken and examination performed to exclude myocardial ischemia or heart failure. The following laboratory tests would be performed preoperatively (baseline values): routine bloods, creatinine, urea, estimated glomerular filtration rate (eGFR), C-reacting proteins (CRP), white blood cell (WBC) count, TnT, N-Terminal pro-Brain Natriuretic Peptide (NT-pro BNP), lipid profile, 12-lead EKG and echocardiography (ECHO).
Anaesthesia and Surgery The surgical and anaesthetic techniques would be determined by physicians responsible for the patient and according to established hospital routines and practices. Patient records would be used for the determination of adverse events according to a standardized protocol. Patient characteristics, pre-operative risk factors, laboratory data and follow-up data would be obtained from medical records. Prophylaxis against deep vein thrombosis, surgical infections and fluid and electrolyte balance would also follow hospital practice. All included patients would be admitted to the post-anaesthesia care unit (PACU) overnight, and longer if deemed necessary by the attending Anaesthesiologist. Patients would be continuously haemodynamically monitored and anaesthesia records would be maintained for independent assessment by a blinded reviewer. Hs-TnT would be repeated in all patients at 24, 48 and 72 h postoperatively. Plasma NT-pro BNP would be re-assessed at 24 h. A 12-lead EKG would be recorded in all patients with elevated high-sensitivity TnT (hs-TnT) at the time of first occurrence and 48 h later. Platelet function tests, microparticles as well as coagulation tests would be performed periodically in the perioperative period. Further laboratory tests would be performed as needed at the discretion of the attending physician.
Coronary artery angiography would be performed within 5 days of detecting a rise in TnT in the study population as well as the control group. The amount of calcium in the vessel wall can be automatically quantified and the plaque can be evaluated as calcified, non-calcified or of mixed composition. The amount of calcium in the vessel wall can be automatically quantified and the plaque can be evaluated as calcified, non-calcified or of mixed composition. The coronary CTA examinations will be analyzed independently by 2 experienced readers who are blinded to all clinical information.
Echocardiography: Protocolized ECHO would be performed 24 h after detection of raised TnT in the study group, and at corresponding time period in a matched group of controls. The ECHO will be recorded and subsequently interpreted by a blinded experienced clinical physiologist/cardiologist to determine wall motion abnormalities and systolic and diastolic function.
When deemed necessary by the attending Cardiologist, the following may also be performed:
Conventional invasive coronary angiography: This will only be done at the discretion of the attending Cardiologist and in agreement with the patient and surgeon at an appropriate time point after surgery, if deemed necessary.
The control group will be matched for age, sex and co-morbidities described in the revised cardiac risk score (myocardial ischemia, cardiac failure, stroke, diabetes mellitus, renal insufficiency and major-risk surgery) (ref) and grouped into < 3 risk factors and >/= 3 risk factors.
তারিখ
সর্বশেষ যাচাই করা হয়েছে: | 01/31/2020 |
প্রথম জমা দেওয়া: | 10/17/2017 |
আনুমানিক তালিকাভুক্তি জমা দেওয়া হয়েছে: | 10/17/2017 |
প্রথম পোস্ট: | 10/22/2017 |
সর্বশেষ আপডেট জমা দেওয়া হয়েছে: | 02/18/2020 |
সর্বশেষ আপডেট পোস্ট: | 02/19/2020 |
আসল অধ্যয়ন শুরুর তারিখ: | 11/30/2017 |
আনুমানিক প্রাথমিক সমাপ্তির তারিখ: | 12/30/2021 |
আনুমানিক অধ্যয়ন সমাপ্তির তারিখ: | 12/30/2021 |
অবস্থা বা রোগ
পর্যায়
বাহু গ্রুপ
বাহু | হস্তক্ষেপ / চিকিত্সা |
---|---|
Myocardial injury Subjects who have had an increase in troponin T level (> 99 percentile) in the perioperative period shall form the cases. | |
Control Subjects who do not have an increase in troponin T level (< 99 percentile) in the perioperative period shall form the controls. |
যোগ্যতার মানদণ্ড
বয়স অধ্যয়নের জন্য যোগ্য | 45 Years প্রতি 45 Years |
লিঙ্গ অধ্যয়নের জন্য যোগ্য | All |
নমুনা পদ্ধতি | Non-Probability Sample |
স্বাস্থ্যকর স্বেচ্ছাসেবীদের গ্রহণ করে | হ্যাঁ |
নির্ণায়ক | Inclusion Criteria: 1. Patients in the age group 45-70 years 2. Major, non-cardiac surgery Exclusion Criteria: 1. Patients with atrial fibrillation 2. Moderate-severe renal insufficiency (GFR < 50) 3. Allergy to iv contrast will be excluded 4. Patients with a preoperative rise in Troponin T 5. Known lung embolism 6. Known deep vein thrombosis (DVT) 7. Inability to comprehend the study or language barriers |
ফলাফল
প্রাথমিক ফলাফল ব্যবস্থা
1. Coronary artery obstruction [< 1 week after rise in Troponin T]
মাধ্যমিক ফলাফলের ব্যবস্থা
1. Protocolized echocardiography [< 48 hours after rise in Troponin T]
2. Lung embolism [< 1 week after rise in Troponin T]
3. Platelet microparticles (PMP) [< 3 days after rise in Troponin T]
4. Calcium score [< 1 week following a rise in TnT]